542334
IGEPAL® CO-630
average Mn 617
Synonym(s):
Polyoxyethylene (9) nonylphenylether, branched
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
General description
IGEPAL® CO-630 is an alkylphenol ethoxylate that is majorly used as an anionic surfactant. It belongs to the IGEPAL series of surfactants, which have hydrophobic chains. Its properties include low surface tension, low sensitivity, and biocompatibility
Application
Nonionic surfactant.
Legal Information
IGEPAL is a registered trademark of Solvay
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
EU REACH SVHC Candidate List
CAS No.
EU REACH Annex XVII (Restriction List)
CAS No.
EU REACH Annex XIV (Authorisation List)
CAS No.
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Preparation of highly concentrated stable dispersions of uniform silver nanoparticles
Journal of Colloid and Interface Science, 260(1), 75-81 (2003)
Wettability of a PTFE surface by cationic-non-ionic surfactant mixtures in the presence of electrolytes
Soft Matter, 8(20), 5429-5433 (2012)
Wetting of TX-100 and Igepal CO-630 Surfactants on a PTFE Surface
Industrial & Engineering Chemistry Research, 50(10), 6138-6145 (2011)
Molecules (Basel, Switzerland), 25(18) (2020-09-24)
Cyclopeptidic chemotherapeutic prodrugs (cPCPs) are macromolecular protease-sensitive doxorubicin (DOX) prodrugs synthesized from a cyclodecapeptidic scaffold, termed Regioselectively Addressable Functionalized Template (RAFT). In order to increase the chemotherapeutic potential of DOX and limit its toxicity, we used a Cathepsin B (Cat
Journal of virology, 83(8), 3684-3695 (2009-02-13)
Vaccinia virus (VACV) replicates in mouse and human fibroblasts with comparable kinetics and efficiency, yielding similar titers of infectious progeny. Here we demonstrate that gamma interferon (IFN-gamma) but not IFN-alpha or IFN-beta pretreatment of mouse fibroblasts prior to VACV infection
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service